To amend the Research and Development, Competition, and Innovation Act to support nucleic acid screening, and for other purposes. | ChamberLight
Bills · HR 3029
PASSED HOUSE· 119TH CONGRESS
House BillHR 3029Biological and life sciencesCell biology and embryology
To amend the Research and Development, Competition, and Innovation Act to support nucleic acid screening, and for other purposes.
INTRO APR 28· LAST ACTION JUL 21
READING
3MIN
COSPONSORS
3BIPARTISAN
READER REACTIONS0 TOTAL
NO VOTES YET · BE THE FIRST
Reported, not passed
LEGISLATIVE PROGRESS
STEP 4 / 8
Introduced
In Committee
Reported
Passed House
Passed Senate
Conference
To President
Became Law
WHAT THE BILL DOES
AI-written
This bill matters because it addresses a growing concern about biosecurity in an age where scientists can increasingly create and manipulate genetic material. If this bill becomes law, it will establish clearer, more standardized ways to screen artificially made DNA and RNA, reducing the chances that potentially dangerous sequences could be created or misused. This is especially important with the rise of artificial intelligence, which could either help in creating new biological materials or introduce new risks.
Without this bill, the development and use of synthetic nucleic acids might continue with a patchwork of varying safety practices, potentially leaving gaps in biosecurity. By setting common standards and fostering collaboration among experts, the bill aims to proactively build a stronger defense against future biological threats, similar to how quality controls are important in other advanced manufacturing industries.
KEY PROVISIONS
4AI-extracted
PROVISION 01
Requires NIST to develop best practices and technical standards for managing risks in engineering biology and biomanufacturing, explicitly including risks from artificial intelligence.
This broadens the scope of biosecurity efforts to cover emerging technologies and advanced manufacturing processes.
PROVISION 02
Directs NIST to carry out measurement research to develop and improve biosecurity measures for nucleic acid synthesis screening.
This focuses on creating robust, science-backed methods for checking the safety of artificially created genetic materials.
PROVISION 03
Mandates NIST to convene a consortium of diverse stakeholders (industry, academia, non-profits) to set priorities and develop best practices for synthetic nucleic acid procurement screening.
This ensures that standards are developed collaboratively with input from those who will implement and be affected by them.
PROVISION 04
Authorizes $5,000,000 per year for fiscal years 2026 through 2030 for NIST to carry out these new biosecurity activities.
This provides dedicated funding necessary for NIST to execute the new research and standard-setting responsibilities.
This bill matters because it addresses a growing concern about biosecurity in an age where scientists can increasingly create and manipulate genetic material. If this bill becomes law, it will establish clearer, more standardized ways to screen artificially made DNA and RNA, reducing the chances that potentially dangerous sequences could be created or misused. This is especially important with the rise of artificial intelligence, which could either help in creating new biological materials or introduce new risks.
Without this bill, the development and use of synthetic nucleic acids might continue with a patchwork of varying safety practices, potentially leaving gaps in biosecurity. By setting common standards and fostering collaboration among experts, the bill aims to proactively build a stronger defense against future biological threats, similar to how quality controls are important in other advanced manufacturing industries.
KEY PROVISIONS
AI-extracted
high
Requires NIST to develop best practices and technical standards for managing risks in engineering biology and biomanufacturing, explicitly including risks from artificial intelligence.
This broadens the scope of biosecurity efforts to cover emerging technologies and advanced manufacturing processes.
high
Directs NIST to carry out measurement research to develop and improve biosecurity measures for nucleic acid synthesis screening.
This focuses on creating robust, science-backed methods for checking the safety of artificially created genetic materials.
med
Mandates NIST to convene a consortium of diverse stakeholders (industry, academia, non-profits) to set priorities and develop best practices for synthetic nucleic acid procurement screening.
This ensures that standards are developed collaboratively with input from those who will implement and be affected by them.
high
Authorizes $5,000,000 per year for fiscal years 2026 through 2030 for NIST to carry out these new biosecurity activities.
This provides dedicated funding necessary for NIST to execute the new research and standard-setting responsibilities.
National Institute of Standards and Technology (NIST) for scientific and technical research and services laboratory activities related to nucleic acid synthesis screening
discretionary
each of fiscal years 2026 through 2030
GLOSSARY
AI-written
Nucleic Acid Synthesis
The process of artificially creating DNA or RNA sequences in a laboratory, rather than extracting them from living organisms.
Biosecurity
Measures taken to prevent the misuse, accidental release, or intentional harmful use of biological agents (like viruses, bacteria, or genetic material) and toxins.
Engineering Biology
The application of engineering principles and practices to biological systems, often involving designing and building new biological parts, devices, and systems.
Biomanufacturing
The production of materials, substances, or products using biological systems, such as microorganisms or cultured cells, often for industrial or medical purposes.
Consortium
A group of organizations, such as businesses, universities, and non-profits, that join together to work on a common project or achieve a shared goal.
Sequence-of-concern Databases
Collections of genetic sequences (DNA or RNA) that have been identified as potentially dangerous or associated with harmful biological agents, used for screening purposes.
Conformity Assessment
ACTION TIMELINE
17 EVENTS
JUL 21
Received in the Senate and Read twice and referred to the Committee on Commerce, Science, and Transportation.
INTROREFERRAL
JUL 20
Mr. Babin moved to suspend the rules and pass the bill, as amended.
FLOOR
JUL 20
Considered under suspension of the rules. (consideration: CR H4666-4667)
FLOOR
JUL 20
DEBATE - The House proceeded with forty minutes of debate on H.R. 3029.
The process of determining whether a product, process, system, or person meets specified requirements, often involving testing, inspection, and certification.
National Institute of Standards and Technology (NIST)
A federal agency that develops and promotes measurement standards and technology to enhance productivity, facilitate trade, and improve public safety and quality of life.
